VIRI - virios.com Annual Revenue Growth (Last Twelve Months)

Graphic logo of Virios Therapeutics, Inc. (VIRI)

Virios Therapeutics focuses on the clinical validation of therapies for fibromyalgia and Long-COVID. This LTM sales volume growth chart versus the previous year visualizes this progress, where 0.00 indicates the current level. Scaling potential is based on global patent distribution, although success is constrained by the risks of failed trials and the necessity for continuous external financing.

VIRI - virios.com Sales Growth YoY (TTM) over the range 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for virios.com (VIRI)

- stock price and consensus target price:
Fundamental company valuation:Virios Therapeutics Inc.
Manufactured product of Virios Therapeutics

The efficiency of Virios Therapeutics (VIRI) in utilizing external production capacities to scale antiviral programs is directly reflected in the TTM revenue growth YoY metric. This indicator measures the percentage change in total revenue over the last twelve months relative to the same period last year, allowing investors to assess the real pace of business expansion and the sustainability of the company's capitalization.